|
1. Bell L, ed. Reference guide to
Drug-Nutrient Interactions. Vancouver: British Columbia Dietitians’ and
Nutritionists’ Association and the British Columbia Pharmacy Association, 1993.
2. Bailey DG, Spence, JD, Munoz C et al.
Interaction of citrus juices with felodipine and nifedipine. Lancet, 1991; 337: 268-9.
Abstract
3. Bailey DG, Spence JD, Edgar B, et al.
Ethanol enhances the hemodynamic effects of felodipine. Clin Invest Med, 1989; 12:
357-62. Abstract
4. Bailey DG, Arnold JMO, Spence JD.
Grapefruit Juice and Drugs - How significant is the interaction ? Clin
Pharmacokinet, 1994: 26: 91-8.
5. Fuhr U, Kummert AL. The fate of
naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther
1995; 58: 363-373. Abstract
6. Anonymous. Grapefruit juice
interactions with drugs. Med Letter Drugs Ther 1995; 37: 73-4.
7. Spence JD. Drug interactions with
grapefruit: whose responsibility is it to warn the public ? Clin Pharmacol Ther
1997; 61: 395-400.
8. Benton RE, Honig PK, Zamani K et al.
Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of
repolarization on the electrocardiogram. Clin Pharmacol Ther 1996, 59: 383-8.
Abstract
9. Josefsson M, Zackrisson A.-L., Ahlner
J. Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy
volunteers. Eur J Clin Pharmacol 1996, 51: 189-93. Abstract
10. Soons PA, Vogels BAPM, Roosemalen MCM et
al. Grapefruit juice and cimetidine inhibit stereoselective metabolism of
nitrendipine in humans. Clin Pharmacol Ther 1991, 50: 394-403. Abstract
11. Bailey DG, Arnold JMO, Strong HA et
al. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics.
Clin Pharmacol Ther; 54: 589-94. Abstract
12. Hollander AAMJ, van Rooij J, Lentjes
EGWM et al. The effect of grapefruit juice on cyclosporine and prednisone metabolism
in transplant patients. Clin Pharmacol Ther 1995; 57: 318-24. Abstract
13. Yee GC, Stanley DL, Pessa LJ et al.
Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995;
345: 955-6.
14. Personal communication, N. Partovi,
Vancouver General Hospital, September 1997.
15. McInnes K. Drug Interactions with
Grapefruit Juice. Drug Information Perspectives, 1997; 17: 7-12.
16. Crixivan (indinavir sulfate) package
insert. Merck & Co., West Point, Penn., March 1996
17. Hukkinen SK, Varhe A, Olkkola KT et
al. Plasma concentrations of triazolam are increased by concomitant ingestion of
grapefruit juice. Clin Pharmacol Ther 1995; 58: 127-31. Abstract
18. Kupferschmidt HHT, Ha HR, Ziegler WH et
al. Interaction between grapefruit juice and midazolam in humans. Clin
Pharmacol Ther 1995; 58: 20-8. Abstract
19. Weber A, Jager R, Borner A et al.
Can grapefruit juice influence ethinyl estradiol bioavailability ? Contraception
1996; 53: 41-7. Abstract
20. Min DI, Ku Y-M, Geraets DR, et al.
Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of
quinidine in healthy volunteers. J Clin Pharmacol 1996; 36: 469-76.
Abstract
21. Bailey DG, Arnold JMO, Munoz et
al. Grapefruit juice-felodipine interaction: mechanism, predictability, and effect
of naringin. Clin Pharmacol Ther 1993;53: 637-42. Abstract
22. Rau SE, Bend JR, Arnold JMO et al.
Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism and
relevance. Clin Pharmacol Ther 1997; 61: 401-9. Abstract
23. Bailey DG, Arnold JMO, Bend JR et
al. Grapefruit juice-felodipine interaction: reproducibility and characterization
with the extended release formulation. Br J Clin Pharmacol 1995; 40: 135-40.
Abstract
24. Schubert W, Cullberg G,
Edgar B et al. Inhibition of 17B-estradiol metabolism by grapefruit juice in
ovariectomized women. Maturitas 1995; 20: 155-163. Abstract
25.James JS: Grapefruit juice and
saquinavir. AIDS Treatment News 235:5-6, 1995.
26. Lown K, Bailey DG, Fontana RJ
et al. Grapefruit juice increases felodipine oral availability in humans by
decreasing intestinal CYP3A protein expression. J Clin Invest 1997; 99: 2545-53.
27. Edwards DJ, Bellvue FH, Woster
PM. Identification of 6',7'-Dihydroxybergamottin, a cytochrome p450 inhibitor in
grapefruit juice. Drug Metabol Disp 1996; 24: 1287-90.
28. Fukuda K, Ohta F, Yamazoe Y.
Grapefruit component interacting with rat and human p450 CYP3A: possible involvement
of non-flavonoid components in drug interaction. Biol Pharm Bull 1997; 20: 560-4.
29. Fukuda K, Ohta T, Oshima Y et
al. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as
components of drug interaction. Pharmacogenetics 1997; 7: 391-6.
30. Fuhr U, Harder S, Lopez-Rojas H
et al. Increase of verapamil concentrations in steady state by coadministration of
grapefruit juice. Naunyn-Schmiedbergs Arch Pharmacol 1996; R134: Abstract 536.
31. Taniguchi S, Kobayashi H, Isii
M. Treatment of psoriasis by cyclosporine and grapefruit juice. Arch Dermatol
1996; 132: 1249.
32. Johnston A, Holt DW. Effect of
grapefruit juice on blood cyclosporin concentration. Lancet 1995; 346: 122-3.
33. Pisarik P. Blood
pressure-lowering effect of adding grapefruit juice to nifedipine and terazosin in a
patient with severe renovascular hypertension. Arch Fam Med 1996; 6: 413-6.
34. Gillis MC ed. Compendium of
Pharmaceuticals and Specialties 33rd ed. Ottawa: Canadian Pharmaceutical Association,
2002.
35. Kantola T et al. Grapefruit juice greatly increases serum
concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1998; 63: 397-402.
Abstract
36. Sullivan DM, Ford MA and Boyden
TW. Grapefruit juice and the response to warfarin. Am J Health-Syst Pharm
1998; 55: 1581-3. Abstract
37. Fuhr U, Maier A, Keller A et al.
Lacking effect of grapefruit juice on theophylline pharmacokinetics. Int J
Clin Pharmacol Ther 1995; 33: 311-4. Abstract
38. Garg SK, Kumar N, Bhargava VK,
Prabhakar SK. Effect of grapefruit juice on carbamazepine bioavailability in patients with
epilepsy. Clin Pharmacol Ther 1998 Sep;64(3):286-8. Abstract
39. Maish WA, Hampton EM, Whitsett TL
et al. Influence of grapefruit juice on caffeine pharmacokinetics and
pharmacodynamics. Pharmacotherapy 1996; 16: 1046-52.
40. Fuhr U, Klittich K, Staib AH.
Inhibitory efffect of grapefruit juice and its bitter principal, naringenin, on CYP 1A2
dependent metabolism of caffeine in man. Br J Clin Pharmacol 1993; 35: 431-6.
41. Ozdemir M,
Aktan Y, Boydag BS. Interaction between grapefruit
juice and diazepam in humans. Eur J Drug
Metab Pharmacokinet 1998 Jan-Mar;23(1):55-9. Abstract
42. Soldner A, Christians U,
Susanto M et al. Grapefruit Juice Activates P-Glycoprotein Mediated Drug Transport. Pharm
Res 1999; 16: 478-85. Abstract
43. Cheng KL, Nafziger AN, Peloquin
CA et al. Effect of Grapefruit Juice on Clarithormycin Pharmacokinetics.
Antimicrob Agents Chemother 1998; 42: 927-9. Abstract
44. Gross AS, Goh YD, Addison RS et
al. Influence of grapefruit juice on cisapride pharmacokinetics. Clin Pharmacol Ther
1999; 65: 395-401. Abstract
45. Sigusch H, Henscel L, Kraul H
et al. Lack of effect of grapefruit juice on diltiazem bioavialablility in normal
subjects. Pharmazie 1994: 49: 675-679. Abstract
46. Lilja, JJ, Kivisto KT, Neovonen PJ. Grapefruit juice-simvastatin interactions: Effect on serum concentrations of
simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther
1998; 64: 477-83. Abstract
47. Pletal Monograph. Otsuka
America Pharmaceutical, Inc. 1999.
48. Ducharme MP, Warbasse LH,
Edwards DJ et al. Disposition of intravenous and oral cyclosporine after administration
with grapefruit juice. Clin Pharmacol Ther 1995; 57: 485-91. Abstract
49. Ducharme MP, Provenzano R, Dehoorne-Smith M et al. Trough concentrations of cyclosporine in blood following
administration with grapefruit juice. Br J Clin Pharmacol 1993: 36: 457-9. Abstract
50. Kupferschmidt HHT, Fattinger KE, Ha HR et al. Grapefruit juice enhances the bioavialability of the HIV protease
inhibitor in man. Br J Clin Pharmacol 1998: 45: 355-9. Abstract
51. Edwards DJ, Fitzsimmons ME,
Schuetz EG et al. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange
juice: effects on cyclosporine disposition, enterocyte CYP 3A4 and P-glycoprotein.
Clin Pharmacol Ther 1999; 65: 237-44. Abstract
52. Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice increases serum concentrations of atorvastatin and has no
effect on pravastatin. Clin Pharmacol Ther 1999; 66: 118-27. Abstract
53. Rogers JD, Zhao J, Liu L et al.
Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Clin Pharmacol Ther
1999; 66: 358-66. Abstract
54. Ho PC, Chalcroft SC, Coville
PF. Grapefruit juice has no effect on quinine pharmacokinetics. Eur J Clin Pharmacol
1999; 55: 393-8. Abstract
55. van Agtmael MA, Gupta V, van
der Wosten TH et al. Grapefruit juice increases the bioavailability of
artemether.
Eur J Clin Pharmacol 1999; 55: 405-10. Abstract
56. Bartle WR. Grapefruit
juice might still be factor in warfarin response. Am J Health-Syst Pharm 1999; 56:
676. Letter
57. Oesterheld J et al.
Grapefruit juice and clomipramine: shifting metabolic ratios. J Clin Psychopharmacol
1997; w17: 62.
58. Baycol product monograph. Bayer
Inc. 1999.
59. Lescol product monograph.
Novartis Pharmaceuticals 1999.
60. Kivisto KT, Lilja JJ, Backman
JT et al. Repeated consumption of grapefruit juice considerably increases plasma
concentrations of cisapride. Clin Pharmacol Ther 1999; 66: 448-53. Abstract
61. Kawakami M, Suzuki K, Ishzuka T
et al. Effect of grapefruit juice on pharmacokinetics of intraconazole in healthy
subjects. Int J Clin Pharmacol Ther 1998; 36: 306-8. Abstract
62. Penzak SR, Gubbins PO, Gurley
BJ et al. Grapefruit Juice decreases the systemic availability of itraconazole
capsules in healthy volunteers. Ther Drug Monit 1999; 21: 304-9. Abstract
63. Kumar N, Garg SK, Prabhakar S.
Lack of pharmacokinetic interaction between grapefruit juice and phenytoin in
healthy male volunteers and epileptic patients. Methods Find Exp Clin Pharmacol 1999; 21:
629-32. Abstract
64. Gupta MC, Garg SK, Badyal D et
al. Effect of Grapefruit Juice on the pharmacokinetics of theophylline in healthy
male volunteers. Methods Find Exp Clin Pharmacol 1999; 21: 679-82. Abstract
65. Libersa CC, Brique SA, Motte KB
et al. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice.
Br J Clin Pharmacol 2000: 49: 373-8. Abstract
66. Damkier P, Hansen LL, Brosen K.
Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin
on the pharmacokinetics of quinidine. Br J Clin Pharmacol 1999; 48: 829-38.
Abstract
67. Eagling VA, Profit L, Back DJ. Inhibition of the CYP3A4-mediated metabolism
and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by
grapefruit juice components. Br J Clin Pharmacol 1999; 48: 543-52. Abstract
68. van Agtmael MA, Gupta V, van
der Graaf CAA et al. The effect of grapefruit juice on the time-dependent decline of
artemether plasma levels in healthy subjects. Clin Pharmacol Ther 1999; 66: 408-14. Abstract
69. Tassaneeyakul W, Tassaneeyakkul
W, Vannaprasaht S et al. Formation of omeprazole sulphone but not
5-hydroxyomeprazole is inhibited by grapefruit juice. Br J Clin Pharamcol 2000; 49:
139-44. Abstract
70. Bailey DG, Dresser
GK, Kreeft JH et al. Grapefruit juice-felodipine interaction: Effect of
segments and an extract from unprocessed fruit. Clin Pharmacol Ther Feb 2000
Abstract PI-71. Abstract
71. Demarles D, Gillotin
C, Bonaventure-Paci S et al. Single-dose pharmacokinetics of amprenavir
co-administered with grapefruit juice. Program and abstracts of the 40th
Interscience Conference on Antimicrobial Agents and Chemotherapy; Toronto,
Ontario, Canada; September 17-20, 2000. Abstract 1649
72. Goldbart A, Press J,
Sofer S et al. Near fatal acute colchicine intoxication in a child. A case
report. Eur J Pediatr 2000; 159: 895-7. Abstract
73. Lilja JJ, Kivisto KT,
Backman JT et al. Effect of grapefruit juice dose on grapefruit juice-triazolam
interaction: repeated consumption prolongs triazolam half-life. Eur J Clin
Pharmacol 2000; 56: 411-5. Abstract
74. Varis T, Kivistro KT,
Neuvonen PJ et al. Grapefruit juice can increase the plasma concentrations of
oral methylprednisolone. Eur J Clin Pharmacol 2000; 56: 489-93. Abstract
75. Kanazawa S, Ohkubo T,
Sugawara K. The effects of grapefruit juice on the pharmacokinetics of
erythromycin. Eur J Clin Pharmacol 2001; 56: 799-803. Abstract
76. Lee AJ, Chan WK,
Harralson AF et al. The effects of grapefruit juice on sertraline metabolism: an
in vitro and in vivo study. Clin Therapeutics 1999; 21: 1890-9. Abstract
77. Nagy J, Schipper HG,
Koopmans RP et al. Effect of grapefruit juice or cimetidine coadministration on
albendazole bioavailability. Am J Trop Med Hyg 2002 Mar;66(3):260-3. Abstract
78. Demarles D, Gillotin
C, Bonaventure-Paci S et al. Single-dose pharmacokinetics of amprenavir
coadministered with grapefruit juice. Antimicrob
Agents Chemother 2002 May;46(5):1589-90. Abstract
79. Lane HY, Chiu CC, Kazmi
Yet al. Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo.
Drug Metabol Drug Interact 2001;18(3-4):263-78. Abstract
80. Lane HY, Jann MW, Chang
YC et al. Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability.
J Clin Psychiatry 2001 Oct;62(10):812-7. Abstract
81. Becquemont L, Verstuyft C, Kerb R et al. Effect of grapefruit juice on digoxin pharmacokinetics in humans.
Clin Pharmacol Ther 2001 Oct;70(4):311-6. Abstract
82. Christensen H, Asberg A, Holmboe AB, Berg KJ. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.
Eur J Clin Pharmacol. 2002 Nov;58(8):515-20. Abstract
83. Dresser GK, Bailey DG, Leake
BF et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of
fexofenadine. Clin Pharmacol Ther 2002 Jan;71(1):11-20. Abstract
84. Charbit B, Becquemont L, Lepère B et al. Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and
halofantrine. lin Pharmacol Ther 2002;72:514-23. Abstract
85. Yasui N, Kondo T, Suzuki
A et al. Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice.
Int Clin Psychopharmacol 1999 Mar;14(2):113-8. Abstract
86. Shelton MJ, Wynn HE, Hewitt
RG et al. Effects of grapefruit juice on pharmacokinetic exposure to indinavir in HIV-positive subjects.
J Clin Pharmacol 2001 Apr;41(4):435-42. Abstract
87. Penzak SR, Acosta EP, Turner
M et al. Effect of Seville orange juice and grapefruit juice on indinavir
pharmacokinetics. J Clin Pharmacol 2002 Oct;42(10):1165-70. Abstract
88. Zaidenstein R, Soback S, Gips M et al. Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers.
Ther Drug Monit 2001 Aug; 23(4):369-73. Abstract
89. Ebert U, Oertel R, Kirch W.
Influence of grapefruit juice on scopolamine pharmacokinetics and pharmacodynamics in healthy male and female subjects.
Int J Clin Pharmacol Ther 2000 Nov;38(11):523-31. Abstract
90. Lilja JJ, Kivisto KT, Neuvonen
PJ. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.
Clin Pharmacol Ther 2000 Oct;68(4):384-90. Abstract
91. Jetter A, Kinzig-Schippers M, Walchner-Bonjean
et al. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther 2002 Jan;71(1):21-9.
Abstract
92. Lilja JJ, Kivisto KT, Backman
JT et al. Grapefruit juice substantially increases plasma concentrations of
buspirone. Clin Pharmacol Ther 1998 Dec;64(6):655-60. Abstract
93. Reif S, Nicolson MC, Bisset D, Reid M, Kloft C, Jaehde U, McLeod HL.
Effect of grapefruit juice intake on etoposide bioavailability. Eur J Clin Pharmacol 2002
Oct;58(7):491-4. Abstract
94. Di Marco MP, Edwards DJ, Wainer IW, Ducharme MP. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of
dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci 2002 Jul 26;71(10):1149-60.
Abstract
95. Malhotra S, Bailey DG, Paine MF, Watkins
PB. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of
furocoumarins. Clin Pharmacol Ther 2001 Jan;69(1):14-23. Abstract
96. Castro N, Jung H, Medina R et al. Interaction between grapefruit juice and praziquantel in humans.
Antimicrob Agents Chemother 2002 May;46(5):1614-6.
Abstract
97. Andersen V, Pedersen N, Larsen NE, Sonne J, Larsen S.
Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice.
Br J Clin Pharmacol 2002 Aug;54(2):120-4. Abstract
98. Yasui
N, Kondo T, Furukori H et al.
Effects of repeated ingestion of
grapefruit juice on the single and multiple oral-dose pharmacokinetics and
pharmacodynamics of alprazolam. Psychopharmacology (Berl) 2000;150(2):185-90.
Abstract
99. Fuhr
U, Muller-Peltzer H, Kern R et al. Effects of grapefruit juice and smoking on
verapamil concentrations in steady state. Eur J Clin Pharmacol 2002
Apr;58(1):45-53. Abstract
100. Desta Z, Kivisto KT, Lilja JJ et al.
Stereoselective pharmacokinetics of cisapride in healthy volunteers and the
effect of repeated administration of grapefruit juice.
Br J Clin Pharmacol 2001
Oct;52(4):399-407. Abstract
101. Zaidenstein
R, Dishi V, Gips M et al. The effect of grapefruit juice on the pharmacokinetics
of orally administered verapamil. Eur
J Clin Pharmacol 1998 Jun;54(4):337-40. Abstract
102. Hashimoto K,
Shirafuji T, Sekino H et al. Interaction of citrus juices with pranidipine, a
new 1,4-dihydropyridine calcium antagonist, in healthy subjects. Eur J Clin
Pharmacol 1998 Nov-Dec;54(9-10):753-60. Abstract
103. Fuhr U,
Maier-Bruggemann A, Blume H, Muck W, Unger S, Kuhlmann J, Huschka C, Zaigler M,
Rietbrock S, Staib AH.
Grapefruit juice increases oral nimodipine bioavailability.
Int J Clin Pharmacol Ther 1998 Mar;36(3):126-32. Abstract
104. Banfield
C, Gupta S, Marino M, Lim J, Affrime M. Grapefruit juice reduces the oral
bioavailability of fexofenadine but not desloratadine. Clin Pharmacokinet
2002;41(4):311-8. Abstract
105.
Allegra (fexofenadine) prescribing information. Physicians'
Desk Reference, Moontvale (NJ): Medical Economics, 2000: 1343-4. Link
to current Allegra prescribing info
106. Bailey DG, Dresser GK, Kreeft JH et
al. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable
active ingredients. Clin Pharmacol
Ther 2000 Nov;68(5):468-77. Abstract
107.
Shi J, Montay G, Leroy B et al. Effects of Itraconazole or Grapefruit Juice
on the Pharmacokinetics of Telithromycin. Pharmacotherapy 2005; 25(1):
42-51. Pubmed
Citation
108.
Lilja JJ, Backman JT, Laitila J et al. Itraconazole increases but grapefruit
juice greatly decreases plasma concentrations of celiprolol. Clin Pharmacol
Ther 2003 Mar: 73: 192-8. PubMed
Citation
109.
Lilja JJ, Juntti-Patinen L, Neuvonen PJ. Orange juice substantially reduces the
bioavailability of the beta-adrenergic-blocking agent celiprolol. Clin Pharmacol
Ther. 2004 Mar;75(3):184-90. PubMed
Citation
110.
Gubbins PO, McConnell SA, Gurley BJ et al. Influence of Grapefruit Juice on
the systemic availability of itraconazole oral solution in healthy adult
volunteers. Pharmacotherapy 2004: 24(4):460-7. PubMed
Citation
111.
Fukazawa I, Uchida N, Yasuhara H. Effects of grapefruit juice on
pharmacokinetics of atorvastatin and pravastatin in Japanese. Br J Clin
Pharmacol 2003: 57(4): 448-55. PubMed
Citation
112.
Benmebarek M, Davaud C, Gex-Farby M et al. Effects of grapefruit juice on
the pharmacokinetics of the enantiomers of methadone. Clin Pharmacol There
2004: 76: 55-63. PubMed
Citation
113.
Kharasch ED, Hoffer C, Whittington D et al. Role of hepatic and intestinal
cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic
effects of methadone. PubMed
Citation
114.
Becquemont L, Verstuyft C, Kerb R et al. Effect of grapefruit juice on
digoxin pharmacokinetics in humans. Clin Pharmacol Ther 2001: 70: 311-6.
PubMed
Citation
115.
Parker RB, Yates CR, Soberman JE et al. Effects of grapefruit juice on
intestinal P-glycoprotein: Evaluation using Digoxin in Humans.
Pharmacotherapy 2003: 23(8): 979-87. PubMed
Citation
116.
Hermans K, Stockman D, Van den Branden F. Grapefruit and Tonic: A deadly
combination in a patient with the Long QT syndrome. Am J Med 2003: 114:
511-2. PubMed
Citation
117.
Egashira K, Fukuda E, Onga T et al. Pomelo-induced increase in the blood
level of tacrolimus in a renal transplant patient. Transplantation 2003:
75(7): 1057. PubMed
Citation
118.
Dreier JP, Endres M. Statin-associated rhabdomyolysis triggered by
grapefruit consumption. Neurology 2004 Feb: 62(4): 670. PubMed
Citation
119.
Hori H, Yoshimura R, Ueda S et al. Grapefruit Juice-Fluvoxamine interaction.
Is it risky or not ? J Clin Psychopharmacol 2003 Aug: 23(4): 422-4. PubMed
Citation
120.
Lilja JJ, Neuvonen M, Neuvonen PJ. Effects of regular consumption of
grapefruit juice on the pharmacokinetics of simvastatin. Br J Clin Pharmacol
2004: 58(1): 56-60. PubMed
Citation
121.
Crestor product Monograph. Astra-Zeneca Pharmaceuticals 2005. Link
to Crestor monograph
122.
Kharasch ED, Whittington D, Hoffer C.
Influence of hepatic and intestinal cytochrome P4503A activity on the acute
disposition and effects of oral transmucosal fentanyl citrate.
Anesthesiology 2004 Sep; 101(3): 729-37. PubMed
Citation
123.
Bailey DG, Dresser GK. Interaction Between Grapefruit Juice and
Cardiovascular Drugs. Am J Cardiovascular Drugs 2004: 4(5): 281-97. PubMed
Citation
124.
Egashira k, Ohtani H, Itoh S. Inhibitory Effects of Pomelo on the Metabolism
of Tacrolimus and the Activities of CYP3A4 and P-glycoprotein. Drug
Metabolism Disposition 2004; 32: 828-33. PubMed
Citation
125.
Kharasch ED, Walker A, Hoffer C et al. Intravenous and oral alfentanil as in
vivo probes for hepatic and first-pass cytochrome P450 3A activity:
non-invasive assessmetn by use of pupillary miosis. Clin Pharmacol Ther
2004; 76: 452-66. PubMed
Citation
126.
Greenblatt DJ, von Moltke LL, Harmatz JS et al. Time course of recovery of
cytochrome P450 3A function after single doses of grapefruit juice. Clin
Pharmacol Ther 2003; 74: 121-9. PubMed
Citation
127.
Ohta T, Nagahashi M, Hosoi S, Tsukamoto S. Dihydroxybergamottin caproate as a potent and stable CYP3A4 inhibitor.
Bioorg Med Chem. 2002 Apr;10(4):969-73. PubMed
Citation
128.
Munoz CF, Ho S, Bend JR et al.Abstract PI-69: Propafenone interaction with
CYP3A4 inhibitors in man. Clin Pharmacol Ther 1997 Feb; 154.
129. Saita T,
Hiroshi F, Mori M. Screening of Furanocoumarin Derivatives in Citrus Fruits
by Enzyme-Linked Immunosorbent Assay. Biol Pharm Bull 2004; 27(7): 974-7. PubMed
Citation
130.
Fujita K, Hidaka M, Takamura N et al. Inhibitory Effects of Citrus Fruits on
cytochrome p450 3A (CYP3A) activity in humans. Boil Pharm Bull 2003; 26:
1371-3. PubMed
Citation
131. Hidaka, M., K. Fujita, et al. Potent
inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. Drug
Metab Dispos 2004; 32(6): 581-3. PubMed
Citation
132. Malhotra, S, Bailey DG, Paine MF et al.
Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of
furocoumarins. Clin Pharmacol Ther 2001; 69(1): 14-23. PubMed
Citation
133. Veronese ML, Gillen LP, Burke JP et
al. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo
by grapefruit juice. J Clin Pharmacol 2003; 43(8): 831-9. PubMed
Citation
134. Wangensteen H, Molden E, Christensen
H et al. Identification of epoxybergamottin as a CYP3A4 inhibitor in
grapefruit peel. Eur J Clin Pharmacol 2003; 58(10): 663-8. PubMed
Citation
135.
Inspra Prescribing Information (US). Pfizer Inc. 2005. Link to Prescribing
Information.
136. Lin HL, Kent UM, Hollenberg PF. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5. J Pharmacol Exp
Ther. 2005; 313: 154-64. PubMed
Citation
|
